NAI Q3 net income up 30.7% to $2.5M; Q4 sales outlook +18-21%

NATURAL ALTERNATIVES INTERNATIONAL INC

2022-Q3 EPS reported $1.22 revenue$118,440,000

Q3 net sales $42.4M (-8.5% YoY); private-label manufacturing down 10.8% due to 40% drop from largest customer.
Net income $2.5M ($0.41 EPS) vs $1.9M ($0.30 EPS) YoY, up 30.7% and 36.7% respectively.
CarnoSyn royalty/license revenue rose 15.2% to $4.8M in Q3; nine-month revenue up 41.7% to $13.5M.
Q4 FY2022 guidance: net sales +18-21% YoY and operating income margin 9-12%.
Cash $18.6M, working capital $53.8M; $20M available on credit line.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.